• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients.新型冠状病毒肺炎患者外周血白细胞分类计数的变化:一项 148 例患者的横断面研究。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2099-2102. doi: 10.1016/j.dsx.2020.10.029. Epub 2020 Nov 2.
2
Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.新型冠状病毒感染患者血液学参数与疾病严重程度的相关性。
J Clin Lab Anal. 2021 Jan;35(1):e23604. doi: 10.1002/jcla.23604. Epub 2020 Nov 13.
3
Clinical and hematological characteristics of 88 patients with COVID-19.88 例 COVID-19 患者的临床和血液学特征。
Int J Lab Hematol. 2020 Dec;42(6):780-787. doi: 10.1111/ijlh.13291. Epub 2020 Jul 23.
4
Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.中性粒细胞与淋巴细胞比值对 COVID-19 的预后意义。
Eur J Clin Invest. 2021 Jan;51(1):e13404. doi: 10.1111/eci.13404. Epub 2020 Sep 25.
5
Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India.评价简单且具有成本效益的免疫血液学标志物,以预测住院严重 COVID-19 患者的结局,重点关注糖尿病 - 印度安得拉邦的回顾性研究。
Diabetes Metab Syndr. 2021 May-Jun;15(3):739-745. doi: 10.1016/j.dsx.2021.03.025. Epub 2021 Mar 29.
6
Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19.中性粒细胞与淋巴细胞比值、淋巴细胞与单核细胞比值及血小板与淋巴细胞比值预测 COVID-19 严重程度。
Am J Emerg Med. 2021 Feb;40:110-114. doi: 10.1016/j.ajem.2020.11.058. Epub 2020 Dec 6.
7
Neutrophil-to-Lymphocyte Ratio, derived Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio as risk factors in critically ill COVID-19 patients, a single centered study.中性粒细胞与淋巴细胞比值、衍生中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值和淋巴细胞与单核细胞比值作为危重症 COVID-19 患者的危险因素:一项单中心研究。
J Ayub Med Coll Abbottabad. 2020 Oct-Dec;32(Suppl 1)(4):S595-S601.
8
Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience.评估血液学参数作为新冠患者疾病严重程度的指标:来自巴基斯坦的经验。
J Clin Lab Anal. 2021 Jun;35(6):e23809. doi: 10.1002/jcla.23809. Epub 2021 May 24.
9
Do initial hematologic indices predict the severity of COVID-19 patients?初始血液学指标能否预测 COVID-19 患者的严重程度?
Turk J Med Sci. 2021 Feb 26;51(1):39-44. doi: 10.3906/sag-2007-97.
10
Association between Hematological Parameters and Severity of COVID-19 disease.血液学参数与 COVID-19 疾病严重程度的相关性。
F1000Res. 2024 Nov 8;13:517. doi: 10.12688/f1000research.148734.2. eCollection 2024.

引用本文的文献

1
Clinical and Paraclinical Peculiarities of SARS-CoV-2 and Influenza Infections in Children: A Comparative Study.儿童感染新型冠状病毒和流感的临床及辅助检查特点:一项对比研究
Life (Basel). 2025 May 14;15(5):784. doi: 10.3390/life15050784.
2
SARS-CoV-2 Infection Positively Correlates with Hyperglycemia and Inflammatory Markers in COVID-19 Patients: A Clinical Research Study.SARS-CoV-2感染与COVID-19患者的高血糖和炎症标志物呈正相关:一项临床研究
Diseases. 2024 Jul 4;12(7):143. doi: 10.3390/diseases12070143.
3
A COVID-19 case report with low ACT(activated clotting time) and high serum D-dimer level: Antithrombin III deficiency?一例活化凝血时间(ACT)低且血清D-二聚体水平高的新型冠状病毒肺炎病例报告:抗凝血酶III缺乏?
Respirol Case Rep. 2024 May 30;12(6):e01394. doi: 10.1002/rcr2.1394. eCollection 2024 Jun.
4
CBC Differences between Survived and Deceased COVID-19 Patients: A Cohort Study.新冠病毒肺炎存活患者与死亡患者的全血细胞计数差异:一项队列研究
Med J Islam Repub Iran. 2023 Sep 6;37:97. doi: 10.47176/mjiri.37.97. eCollection 2023.
5
The Evaluation of Laboratory Parameters as Predictors of Disease Severity and Mortality in COVID-19 Patients: A Retrospective Study From a Tertiary Care Hospital in India.实验室参数作为COVID-19患者疾病严重程度和死亡率预测指标的评估:来自印度一家三级护理医院的回顾性研究。
Cureus. 2023 Jun 11;15(6):e40273. doi: 10.7759/cureus.40273. eCollection 2023 Jun.
6
Assessment of COVID-19 RT-PCR Positive Symptomatic Patients With Clinical, Hematological, and Radiological Parameters Among Three Groups: A Comparative Study.三组中COVID-19逆转录聚合酶链反应阳性有症状患者的临床、血液学和放射学参数评估:一项比较研究
Cureus. 2023 May 30;15(5):e39681. doi: 10.7759/cureus.39681. eCollection 2023 May.
7
Molecular and Physiological Study in Patients with Coronavirus in Thi-Qar Province Iraq.伊拉克济加尔省冠状病毒患者的分子与生理研究。
Arch Razi Inst. 2022 Oct 31;77(5):2001-2006. doi: 10.22092/ARI.2022.358337.2199. eCollection 2022 Oct.
8
Clinical Significance and Diagnostic Utility of NLR, LMR, PLR and SII in the Course of COVID-19: A Literature Review.中性粒细胞与淋巴细胞比值、淋巴细胞与单核细胞比值、血小板与淋巴细胞比值及全身免疫炎症指数在新型冠状病毒肺炎病程中的临床意义及诊断价值:文献综述
J Inflamm Res. 2023 Feb 11;16:539-562. doi: 10.2147/JIR.S395331. eCollection 2023.
9
Recent advances in understanding the role of eosinophils.嗜酸性粒细胞作用认识的最新进展。
Fac Rev. 2022 Sep 27;11:26. doi: 10.12703/r/11-26. eCollection 2022.
10
Epigenetic activation of antiviral sensors and effectors of interferon response pathways during SARS-CoV-2 infection.SARS-CoV-2 感染期间抗病毒传感器和干扰素反应途径效应物的表观遗传激活。
Biomed Pharmacother. 2022 Sep;153:113396. doi: 10.1016/j.biopha.2022.113396. Epub 2022 Jul 11.

本文引用的文献

1
COVID-19 Hyperinflammation: What about Neutrophils?COVID-19 超高炎症反应:中性粒细胞怎么了?
mSphere. 2020 Jun 24;5(3):e00367-20. doi: 10.1128/mSphere.00367-20.
2
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York.在纽约布朗克斯的 COVID-19 患者队列中,严重肥胖、年龄增长和男性性别与住院期间的不良结局独立相关,并与更高的住院死亡率相关。
Metabolism. 2020 Jul;108:154262. doi: 10.1016/j.metabol.2020.154262. Epub 2020 May 16.
3
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.中性粒细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在 COVID-19 患者中的诊断及预测作用。
Int Immunopharmacol. 2020 Jul;84:106504. doi: 10.1016/j.intimp.2020.106504. Epub 2020 Apr 13.
4
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度:一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
5
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.中性粒细胞与淋巴细胞比值可作为 COVID-19 住院患者死亡的独立危险因素。
J Infect. 2020 Jul;81(1):e6-e12. doi: 10.1016/j.jinf.2020.04.002. Epub 2020 Apr 10.
6
Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.2019年冠状病毒病(COVID-19)重症患者的中性粒细胞与淋巴细胞比值及淋巴细胞与C反应蛋白比值:一项荟萃分析。
J Med Virol. 2020 Oct;92(10):1733-1734. doi: 10.1002/jmv.25819. Epub 2020 Apr 8.
7
Diabetes is a risk factor for the progression and prognosis of COVID-19.糖尿病是新冠病毒疾病(COVID-19)进展和预后的一个风险因素。
Diabetes Metab Res Rev. 2020 Oct;36(7):e3319. doi: 10.1002/dmrr.3319. Epub 2020 Apr 7.
8
The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients.94 例新冠肺炎出院患者病毒清除与生化结局的相关性。
Inflamm Res. 2020 Jun;69(6):599-606. doi: 10.1007/s00011-020-01342-0. Epub 2020 Mar 29.
9
Covid-19: risk factors for severe disease and death.新冠病毒病:重症和死亡的风险因素
BMJ. 2020 Mar 26;368:m1198. doi: 10.1136/bmj.m1198.
10
Clinical features and treatment of COVID-19 patients in northeast Chongqing.重庆东北部地区 COVID-19 患者的临床特征和治疗方法。
J Med Virol. 2020 Jul;92(7):797-806. doi: 10.1002/jmv.25783. Epub 2020 Apr 1.

新型冠状病毒肺炎患者外周血白细胞分类计数的变化:一项 148 例患者的横断面研究。

Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients.

机构信息

Department and Institution: Department of Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, 834009, India.

Department and Institution: Department of Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, 834009, India.

出版信息

Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2099-2102. doi: 10.1016/j.dsx.2020.10.029. Epub 2020 Nov 2.

DOI:10.1016/j.dsx.2020.10.029
PMID:33160224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7605785/
Abstract

BACKGROUND

SARS-CoV-2 infection alters various blood parameters, which may indicate disease severity and thus help in better clinical management.

AIM

To study the association between various hematological parameters and disease severity of COVID-19. To analyze the effects of hypertension and diabetes on neutrophil-lymphocyte ratio and neutrophil-monocyte ratio in patients suffering from COVID-19.

MATERIALS AND METHODS

The study was a cross-sectional study involving 148 laboratory-confirmed cases of SARS-CoV-2 infection. The patients were divided into three groups on the basis of disease severity. Various hematological parameters were analyzed. The effects of hypertension and diabetes on NLR and NMR in COVID-19 patients were evaluated.

RESULTS

Of the 148 patients, 78.4%, 8.1% and 13.5% cases were in the mild, moderate and severe groups, respectively. Mean age was 42.63 ± 16.04 years (IQR: 29, 54.75; Range: 7-74). 58.8% patients were male while the rest (42.2%) were female. Mean TLC (cells/mm), neutrophil (%), lymphocyte (%), monocyte (%), eosinophil (%), neutrophil-lymphocyte ratio (NLR) and neutrophil-monocyte ratio (NMR) among mild, moderate and severe COVID-19 was statistically significant (p < 0.05). Basophil (%) and lymphocyte-monocyte ratio (LMR) was statistically insignificant among the three groups. Lymphocyte (%), monocyte (%) and eosinophil (%) were negatively correlated to disease severity. Among diabetics, both NLR and NMR were statistically significant (p < 0.05). However, among hypertensive cases, only the NLR was statistically significant.

CONCLUSION

Older age, higher TLC, neutrophilia, lymphopenia, eosinopenia, high NLR and high NMR are associated with severe COVID-19. High NLR and high NMR are indicative of severe disease among diabetic patients. High NLR also indicates severe disease among hypertensive patients.

摘要

背景

SARS-CoV-2 感染会改变各种血液参数,这些参数可能表明疾病的严重程度,从而有助于更好的临床管理。

目的

研究各种血液参数与 COVID-19 疾病严重程度之间的关系。分析高血压和糖尿病对患有 COVID-19 的患者中性粒细胞与淋巴细胞比值和中性粒细胞与单核细胞比值的影响。

材料和方法

这是一项横断面研究,共纳入 148 例经实验室确诊的 SARS-CoV-2 感染患者。根据疾病严重程度将患者分为三组。分析各种血液参数。评估高血压和糖尿病对 COVID-19 患者 NLR 和 NMR 的影响。

结果

在 148 例患者中,78.4%、8.1%和 13.5%的患者分别处于轻症、中症和重症组。平均年龄为 42.63±16.04 岁(IQR:29,54.75;范围:7-74)。58.8%的患者为男性,其余 42.2%为女性。轻度、中度和重度 COVID-19 患者的平均 TLC(细胞/mm)、中性粒细胞(%)、淋巴细胞(%)、单核细胞(%)、嗜酸性粒细胞(%)、中性粒细胞与淋巴细胞比值(NLR)和中性粒细胞与单核细胞比值(NMR)差异均有统计学意义(p<0.05)。三组间嗜碱性粒细胞(%)和淋巴细胞与单核细胞比值(LMR)差异无统计学意义。淋巴细胞(%)、单核细胞(%)和嗜酸性粒细胞(%)与疾病严重程度呈负相关。在糖尿病患者中,NLR 和 NMR 均有统计学意义(p<0.05)。然而,在高血压患者中,只有 NLR 有统计学意义。

结论

年龄较大、TLC 较高、中性粒细胞增多、淋巴细胞减少、嗜酸性粒细胞减少、高 NLR 和高 NMR 与 COVID-19 重症相关。糖尿病患者的高 NLR 和高 NMR 提示疾病严重。高血压患者的高 NLR 也提示疾病严重。